Screening for Prostate Cancer in Older Patients (PLCO Screening Trial)

StatusActive, Not Recruiting
PhaseNot applicable
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

The 50 most recent of 103 record versions are accounted for below. See every version on ClinicalTrials.gov ↗

  1. Re-verified, no change to tracked fieldsv103
  2. Study completion date: Mar 25, 2026 to Jun 30, 2027v102
  3. Re-verified, no change to tracked fieldsv101
  4. Study completion date: Mar 11, 2025 to Mar 25, 2026
    • Interventions: Laboratory Biomarker Analysis (Other), Medical Examination (Procedure), Screening Questionnaire Administration (Other) to Laboratory Biomarker Analysis (Other), Medical Examination Assessment (Procedure), Screening Questionnaire Administration (Other)
    v100
  5. 2 versions Re-verified since Jul 24, 2024, no change to tracked fieldsv98-v99
Show 44 earlier versionsHide 44 earlier versions
  1. Study completion date: Mar 11, 2025v97
  2. 19 versions Re-verified since Jun 15, 2017, no change to tracked fieldsv78-v96
  3. Primary completion date: May 2012 to May 21, 2012
    • Start date: Nov 1993 to Nov 16, 1993
    v77
  4. Re-verified, no change to tracked fieldsv76
  5. Study site revisedv75
  6. 7 versions Re-verified since Nov 9, 2015, no change to tracked fieldsv68-v74
  7. Interventions: examination (Procedure), laboratory biomarker analysis (Other), screening questionnaire administration (Other) to Laboratory Biomarker Analysis (Other), Medical Examination (Procedure), Screening Questionnaire Administration (Other)v67
  8. Results first posted: Jun 26, 2014v66 Show 5 more changesShow less
    • Primary completion date: Sep 2001 to May 2012
    • Primary endpoints: 1 to 2
    • Enrollment target: estimated 74000 to confirmed 76685
    • Interventions: cytology specimen collection procedure (Other), examination (Procedure), screening questionnaire administration (Other) to examination (Procedure), laboratory biomarker analysis (Other), screening questionnaire administration (Other)
    • Secondary endpoints: 1 to 15
  9. Re-verified, no change to tracked fieldsv65
  10. Enrollment target: 74000v64 Show 8 more changesShow less
    • Study sites: 9 to 1
    • Primary completion date: Sep 2001
    • Interventions: long-term screening (Procedure), screening questionnaire administration (Other) to cytology specimen collection procedure (Other), examination (Procedure), screening questionnaire administration (Other)
    • Eligibility criteria expanded, about 97 words
    • Study description shortened, about 46 words
    • Publications: 79 to 29
    • Study arms: 0 to 2
    • Study title shortened, about 4 words
  11. Publications: 78 to 79v63
  12. Publications: details revised at 1 of 78 entriesv62
  13. Publications: 77 to 78v61
  14. Publications: 76 to 77v60
  15. Publications: 74 to 76v59
  16. Publications: details revised at 1 of 74 entriesv58
  17. Publications: 73 to 74v57
  18. Publications: 72 to 73v56
  19. Publications: details revised at 1 of 72 entriesv55
  20. Publications: details revised at 1 of 72 entriesv54
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This clinical trial studies whether screening methods used to diagnose cancer of the prostate, lung, colon, rectum, or ovaries can reduce deaths from these cancers. Screening tests may help doctors find cancer cells early and plan better treatment for prostate cancer.
Trial Details
NCT Number NCT00002540
Lead Sponsor National Cancer Institute (NCI)
Conditions
(from sponsor)		 Prostate Carcinoma
Related terms Prostatic Neoplasms
Enrollment 76,685 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov